Patients (n = 80) (mean ± SD) (min-max) | Control (n = 40) P value (mean ± SD) (min-max) | P value | |
Age (years) | 47.22 ± 10.31 (20 - 65) | 43.12 ± 8.11 (23 - 70) | 0.105 |
Males/Females % (n) | 15%/85% (12 - 68) | % 25/%75 (30 - 10) | 0.182 |
Body mass index (kg/m2) | 32.73 ± 5 ( 22 - 45) | 31.18 ± 4.4 (26 - 42) | 0.058 |
SF-36 subgroups | |||
Physical function (PF) | 60.17 ± 21.3 (24 - 100) | 79.12 ± 10.8 (50 - 100) | 0.000* |
Role physical (RP) | 45.31 ± 41.1 (0 - 100) | 80 ± 29.5 (0 - 100) | 0.000* |
Bodily pain(BP) | 41.38 ± 17.4 (10 - 84) | 67.90 ± 17.8 (10 - 100) | 0.000* |
General health (GH) | 42.21 ± 17.7 (0 - 87) | 57.47 ± 13.9 (5 - 82) | 0.000* |
Vitality (VT) | 32.83 ± 23.3 (0 - 85) | 49.25 ± 16.9 (0 - 75) | 0.000* |
Social function (SF) | 55.60 ± 25.9 (0 - 100) | 80.62 ± 19.6 (0 - 100) | 0.000* |
Role emotional (RE) | 40.39 ± 40.6 (0 - 100) | 77.16 ± 32.9 (0 - 100) | 0.000* |
Mental health (MH) | 42.85 ± 18.12 (0 - 88) | 63.27 ± 18.3 (36 - 100) | 0.000* |
PCS | 39.49 ± 9.3 (23.2 - 58.80) | 65.95 ± 13.2 (34.4 - 86) | 0.000* |
MCS | 34.78 ± 10.3 (9.2 - 58.50) | 64.98 ± 12.7 (40 - 88.4) | 0.000* |
MAF subgroups (mean) (min-max) | |||
MAF-1 (degree) | 6.26 ± 2.51 (0 - 10) | 4.42 ± 2.26 (0 - 9) | 0.000* |
MAF-2 (severity) | 6.08 ± 2.61 (0 - 10) | 4.12 ± 2.55(0 - 9) | 0.000* |
MAF-3 (distress) | 5.98 ± 2.64 (0 - 9) | 3.82 ± 2.30 (0 - 8) | 0.000* |
MAF-4 (ADLs) | 5.35 ± 2.39 (0 - 8.81) | 3.53 ± 2.0 (0 - 7) | 0.000* |
MAF-5 (timing) | 6.23 ± 2.66 (0 - 10) | 4.26 ± 2.53 (0 - 10) | 0.000* |
MAF total | 29.97 ± 12.11 (0 - 47.47) | 19.92 ± 11.01(0 - 38) | 0.000* |